Gatekeeper function of the RUNX1 transcription factor in acute leukemia

被引:29
作者
Niebuhr, Birte [1 ]
Fischer, Meike [1 ]
Taeger, Maike [1 ]
Carnmenga, Jorg [2 ]
Stocking, Carol [1 ]
机构
[1] Heinrich Pette Inst, D-25051 Hamburg, Germany
[2] Lund Univ, Lund Strateg Ctr Stem Cell Biol & Cell Therapy, SE-221 Lund, Sweden
关键词
leukemia stem cell; core-binding factor; differentiation; self-renewal;
D O I
10.1016/j.bcmd.2007.07.018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The RUNX1 gene encodes the alpha subunit of the core binding factor (CBF) and is a common target of genetic mutations in acute leukemia. We propose that RUNX1 is a gatekeeper gene, the disruption of which leads to the exodus of a subset of hematopoietic progenitors with increased self-renewal potential from the normal environmental controls of homeostasis. This pool of "escaped" cells is the target of secondary mutations, accumulating over time to induce the aggressive manifestation of acute leukemia. Evidence from patient and animal studies supports the concept that RUNX1 Mutations are the initiating event in different leukemia subtypes, but also suggests that diverse mechanisms are used to subvert RUNX1 function. One common result is the inhibition of differentiation-but its effect impinges on different lineages and stages of differentiation, depending on the mutation or fusion partner. A number of different approaches have led to the identification of secondary events that lead to the overt acute phase; however, the majority is unknown. Finally, the concept of the "leukemia stern cell" and its therapeutic importance is discussed in light of the RUNX1 gatekeeper function. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:211 / 218
页数:8
相关论文
共 81 条
[11]   Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias [J].
Care, RS ;
Valk, PJM ;
Goodeve, AC ;
Abu-Duhier, FM ;
Geertsma-Kleinekoort, WMC ;
Wilson, GA ;
Gari, MA ;
Peake, IR ;
Löwenberg, B ;
Reilly, JT .
BRITISH JOURNAL OF HAEMATOLOGY, 2003, 121 (05) :775-777
[12]   The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia [J].
Castilla, LH ;
Garrett, L ;
Adya, N ;
Orlic, D ;
Dutra, A ;
Anderson, S ;
Owens, J ;
Eckhaus, M ;
Bodine, D ;
Liu, PP .
NATURE GENETICS, 1999, 23 (02) :144-146
[13]   Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia [J].
Castilla, LH ;
Perrat, P ;
Martinez, NJ ;
Landrette, SF ;
Keys, R ;
Oikemus, S ;
Flanegan, J ;
Heilman, S ;
Garrett, L ;
Dutra, A ;
Anderson, S ;
Pihan, GA ;
Wolff, L ;
Liu, PP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (14) :4924-4929
[14]   Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia [J].
Castor, A ;
Nilsson, L ;
Åstrand-Grundström, I ;
Buitenhuis, M ;
Ramirez, C ;
Anderson, K ;
Strömbeck, B ;
Garwicz, S ;
Békássy, AN ;
Schmiegelow, K ;
Lausen, B ;
Hokland, P ;
Lehmann, S ;
Juliusson, G ;
Johansson, B ;
Jacobsen, SEW .
NATURE MEDICINE, 2005, 11 (06) :630-637
[15]   Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation [J].
de Guzman, CG ;
Warren, AJ ;
Zhang, Z ;
Gartland, L ;
Erickson, P ;
Drabkin, H ;
Hiebert, SW ;
Klug, CA .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5506-5517
[16]   Role of RUNX family members in transcriptional repression and gene silencing [J].
Durst, KL ;
Hiebert, SW .
ONCOGENE, 2004, 23 (24) :4220-4224
[17]   Cancer revoked: oncogenes as therapeutic targets [J].
Felsher, DW .
NATURE REVIEWS CANCER, 2003, 3 (05) :375-380
[18]   Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model [J].
Fischer, M ;
Schwieger, M ;
Horn, S ;
Niebuhr, B ;
Ford, A ;
Roscher, S ;
Bergholz, U ;
Greaves, M ;
Löhler, J ;
Stocking, C .
ONCOGENE, 2005, 24 (51) :7579-7591
[19]   Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia [J].
Ford, AM ;
Bennett, CA ;
Price, CM ;
Bruin, MCA ;
Van Wering, ER ;
Greaves, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4584-4588
[20]   Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia [J].
Goemans, BF ;
Zwaan, CM ;
Miller, M ;
Zimmermann, M ;
Harlow, A ;
Meshinchi, S ;
Loonen, AH ;
Hählen, K ;
Reinhardt, D ;
Creutzig, U ;
Kaspers, GJL ;
Heinrich, MC .
LEUKEMIA, 2005, 19 (09) :1536-1542